Are Trigyn Technologies Ltd latest results good or bad?

2 hours ago
share
Share Via
Trigyn Technologies Ltd's latest results show mixed performance, with a 5.13% year-on-year sales growth but a significant 75.39% decline in net profit, raising concerns about operational efficiency and reliance on non-operating income. Overall, the company faces challenges in profitability and revenue momentum.
Trigyn Technologies Ltd's latest financial results for the quarter ended March 2026 reveal a complex picture of operational challenges and profitability concerns. The company reported net sales of ₹251.95 crores, reflecting a year-on-year growth of 5.13%. However, this figure represents a sequential decline of 2.36% from the previous quarter, indicating potential issues with revenue momentum, possibly due to seasonal factors or project completions.
The operating profit margin, excluding other income, was recorded at a mere 1.42%, which is significantly low and raises concerns about the company's operational efficiency. This margin has seen a slight improvement from the previous quarter's 0.06%, yet it remains below the 2.30% achieved in the same quarter last year. The company's net profit for the quarter was ₹0.63 crores, which marks a substantial year-on-year decline of 75.39% and a sequential decrease of 8.70%. This decline highlights a troubling trend in profitability, as the company struggles to convert its revenue into meaningful earnings. A critical aspect of the financial results is the company's heavy reliance on non-operating income, which constituted 68.31% of profit before tax. This dependence raises questions about the sustainability of the reported earnings and suggests that core operations are not generating sufficient returns. Furthermore, the return on equity (ROE) for the latest quarter was a low 0.64%, indicating significant capital inefficiency and a decline from the five-year average of 4.12%. In terms of balance sheet strength, Trigyn Technologies maintains a virtually debt-free position, with a net debt-to-equity ratio of negative 0.49, indicating more cash than debt. This provides some financial flexibility, but the lack of operational improvement raises concerns about the effective deployment of these resources. Overall, the financial data suggests that Trigyn Technologies is facing significant operational challenges, with deteriorating profitability and a concerning reliance on non-operating income. The company has seen an adjustment in its evaluation, reflecting the market's perception of these ongoing issues. Investors may need to closely monitor the company's ability to improve its operational efficiency and profitability in the coming quarters.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Trigyn Technologies Ltd is Rated Sell
May 20 2026 10:10 AM IST
share
Share Via
Trigyn Technologies Ltd is Rated Sell
May 09 2026 10:10 AM IST
share
Share Via
Trigyn Technologies Ltd is Rated Sell
Apr 28 2026 10:10 AM IST
share
Share Via
Trigyn Technologies Ltd is Rated Sell
Apr 17 2026 10:10 AM IST
share
Share Via
Trigyn Technologies Ltd is Rated Sell
Apr 06 2026 10:10 AM IST
share
Share Via